Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Resources for Biomarker Requestors
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Generic Drug Facilities, Sites and Organization Lists
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Laboratory Information Bulletins
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-09 By FDA
Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-09
Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 37, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-09
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Date of authorisation: 06/06/2025, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-09
Bayesian Statistical Analysis (BSA) Demonstration Project
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 16, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-09
Compounding Quality Center of Excellence | Annual Conference - 08/25/2025
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Generic Drug User Fee Amendments
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Institutional Review Board (IRB) Written Procedures
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
User Fee Lists
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 38, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-09
Compounding Quality Center of Excellence | Annual Conference
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.